Breast MRI texture analysis for prediction of BRCA-associated genetic risk
Abstract Background BRCA1/2 deleterious variants account for most of the hereditary breast and ovarian cancer cases. Prediction models and guidelines for the assessment of genetic risk rely heavily on criteria with high variability such as family cancer history. Here we investigated the efficacy of...
Main Authors: | Georgia Vasileiou, Maria J. Costa, Christopher Long, Iris R. Wetzler, Juliane Hoyer, Cornelia Kraus, Bernt Popp, Julius Emons, Marius Wunderle, Evelyn Wenkel, Michael Uder, Matthias W. Beckmann, Sebastian M. Jud, Peter A. Fasching, Alexander Cavallaro, André Reis, Matthias Hammon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Medical Imaging |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12880-020-00483-2 |
Similar Items
-
BRCA Testing in Serbia and Montenegro
by: Brankovic-Magic Mirjana
Published: (2006-10-01) -
Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01) -
Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01) -
Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC
by: Zheyuan Xu, et al.
Published: (2021-02-01) -
Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
by: Falk Zakrzewski, et al.
Published: (2019-04-01)